IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with the CEO & Co-Founder of System1, LLC to discuss an overview of the company, System1’s […]

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–HomeSmart, a revolutionary real estate enterprise powered by a proprietary end-to-end technology platform, today announced that it has publicly filed a registration statement on Form S-1 with the […]

KENNESAW, Ga.–(BUSINESS WIRE)–ShoulderUp Technology Acquisition Corp. (the “Company”) announced today that, commencing January 10, 2022, holders of the 30,000,000 units sold in the Company’s initial public offering may elect to […]

WASHINGTON–(BUSINESS WIRE)–C5 Acquisition Corporation (the “Company”), a special purpose acquisition company, announced the pricing of its initial public offering (“IPO”) of 25,000,000 units at a price of $10.00 per unit. […]

SEATTLE–(BUSINESS WIRE)–ALSP Orchid Acquisition Corporation I (Nasdaq: ALORU) (the “Company” or “ALSP Orchid”) announced today that, commencing January 10, 2022, holders of the units sold in the Company’s initial public […]

NEW YORK–(BUSINESS WIRE)–INFINT Acquisition Corporation (NYSE: IFIN.U) (the “Company”) today announced that holders of the units sold in the Company’s initial public offering completed on November 18, 2021 may elect […]

CHARLOTTE, N.C.–(BUSINESS WIRE)–$HYM #3Dprinting—Hyperion Metals Limited (ASX: HYM) (“Company”) is pleased to announce that it plans to pursue a listing on a national securities exchange in the United States and […]

Largest IPO of Public Acquisition Vehicle since March 2021 $10.00 per Unit to be Deposited in Trust NEW YORK–(BUSINESS WIRE)–Screaming Eagle Acquisition Corp. (the “Company”), the eighth public acquisition vehicle […]

SAN FRANCISCO & FORT WORTH, Texas–(BUSINESS WIRE)–TPG, a leading global alternative asset management firm, today announced that it has commenced an initial public offering of 33,900,000 shares of its Class […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the launch of […]